ASLAN Pharmaceuticals Files For $86 Million U.S. IPO

Singapore-based ASLAN Pharmaceuticals aims to raise $86 million in a U.S. IPO. The Taipei-listed firm has a pipeline of late-stage treatment candidates for various cancers that are prevalent in Asia. Management's collaborative efforts and the company's ... ( read original story ...)

Vietnam’s so far biggest IPO gets underway

more than the hitherto largest IPO of Vincom Retail, which raised about $700 million last year. The bank has already attracted global funds as cornerstone investors, including Singapore wealth fund GIC, Fidelity Management and Research and Dragon Capital. ( read original story ...)

ASLAN Pharmaceuticals Updates U.S. IPO Plans

Singapore-based ASLAN Pharmaceuticals was founded in 2010 as ... There is no indication of existing shareholders intending to purchase shares at the IPO price. For biopharma IPOs, it is currently typical for at least one existing shareholder to support ... ( read original story ...)

ICBC Singapore unveils investment banking services

Corporate finance advisory services which include follow-on fund raisings, reverse takeovers, M&A advisory services, private equity and pre-IPO fund raisings in Singapore, Malaysia, and Indonesia are another area of business focus. “With the continuous ... ( read original story ...)

Top finance positions in demand by Singapore employers

SINGAPORE: The top three finance and accounting positions in demand by Singapore employers this year are: financial planning and analysis managers, who can expect to earn a median salary of S$115,000; finance managers, with a salary of S$110,000; and tax ... ( read original story ...)

Is the Singapore Stock Market Cheap or Expensive Right Now?

Knowing how cheap the stock market currently is, can help us to simplify our investing decision. There are two methods to find out if Singapore stocks are a steal or are in an overheated territory right now. The first method is to compare the market’s ... ( read original story ...)